News & Updates

Treatment with low-dose naltrexone does not appear to reduce nociceptive pain among patients with arthritis, as reported in a small pilot study.

A Medicare cohort study has found a very high 30-day rehospitalization rate among young adults with systemic lupus erythematosus (SLE).

Among people with gout, reducing serum urate levels to the guideline-based target level appears to contribute to a protective effect on the risk of incident fracture, according to a study.

Ageing is independently associated with seronegative rheumatoid arthritis (RA) in patients who are female, have a nonsmoking history, and a body mass index (BMI) <25 kg/m2, according to a study.

Supplementation with vitamin E fixes the intestinal barrier and the gastrointestinal tract, which then helps prevent and treat rheumatoid arthritis (RA), reveals a study.

A diagnosis of discoid lupus erythematosus (DLE) at age 25 years or below, phototype V to VI, and antinuclear antibody titers of ≥1:320 are significantly associated with the development of severe systemic lupus erythematosus (SLE), according to a study.

For patients with rheumatoid arthritis (RA) or psoriatic arthritis (PsA), initiation of Janus kinase (JAK) inhibitor treatment does not carry a higher short-term risk of cancer, with the exception of nonmelanoma skin cancer (NMSC), as compared with initiation of biological disease-modifying antirheumatic drugs (bDMARDs) including tumour necrosis factor (TNF) inhibitors, according to a study.

Use of antihypertensive agents that modify the renin-angiotensin system (RAS) helps lower the risk of cardiovascular disease (CVD) in patients with systemic lupus erythematosus (SLE), suggests a study.